Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3)

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3)

EDITORIAL  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):209-11

Promoting nuclear medicine in developing countries through IAEA coordinated research projects: Technical Reports Series 458 and 459

Duatti A.

PDF

FOREWORD  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):212-4

Imagine the imagery: opportunities and challenges

Cutler C. S., McQuarrie S., Smith S. V.

PDF

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):215-21

Small animal PET in preclinical studies: opportunities and challenges

Riemann B., Schäfers K. P., Schober O., Schäfers M.

Abstract PDF

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):222-34

Radiometal complexes: characterization and relevant in vitro studies

Jurisson S., Cutler C., Smith S. V.

Abstract PDF

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):235-44

In vitro assays for assessing the potential for copper complexes to function as radiopharmaceutical agents

Barnard P. J., Bayly S. R., Holland J. P., Dilworth J. R., Waghorn P. A.

Abstract PDF

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):245-53

In vitro receptor binding assays: general methods and consideration

Bigott-Hennkens H. M., Dannoon S., Lewis M. R., Jurisson S. S.

Abstract PDF

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):254-66

Cytochrome P450 and radiopharmaceutical metabolism

Giron M. C., Portolan S., Bin A., Mazzi U., Cutler C. S.

Abstract PDF

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):267-77

Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles

Shokeen M., Fettig N. M., Rossin R.

Abstract PDF

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):278-88

A review of basic principles of fractals and their application to pharmacokinetics

Marsh R. E., Riauka T. A., McQuarrie S. A.

Abstract PDF

ORIGINAL ARTICLES  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):289-95

Activation of intrinsic apoptotic pathway by Re-188 irradiation and paclitaxel in coronary artery smooth muscle cells

Friesen C., Lubatschofski A., Glatting G., Debatin K. M., Reske S. N.

Abstract PDF

ORIGINAL ARTICLES  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):296-304

Poststress left ventricular ejection fraction is an independent predictor of major cardiac events in patients with coronary artery disease and impaired left ventricular function

De Winter O., Van De Veire N., De Bondt P., Van De Wiele C., De Buyzere M., De Backer G., Gillebert T. C., Dierckx R. A., De Sutter J.

Abstract PDF

ORIGINAL ARTICLES  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):305-16

Biodistribution, cellular uptake and DNA-incorporation of the 2’-fluoro stabilized 5-iodo-2’-deoxyuridine analog 5-iodo-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)uracil (FIAU)

Morgenroth A., Deisenhofer S., Neininger M., Vogg A. T. J., Glatting G., Kull T., Reske S. N.

Abstract PDF

top of page